Tempus AI (Ticker: TEM US) is a healthcare technology company that provides data and analytics tools for precision medicine, focusing on the use of artificial intelligence in healthcare, led by CEO Eric Lefkofsky, co-founder of Groupon.

Chicago-based Tempus AI is expected to list on June 14, 2024 on Nasdaq. The firm is selling 11,100,000 shares at a price of $35.00 to $37.00 per share. The expected market capitalization at offer is $5.9 billion. The total offer size is approximately $400 million. The offering is managed by Morgan Stanley, J.P. Morgan, Allen & Company, BofA Securities, TD Cowen, Stifel, and William Blair, with Loop Capital Markets and Needham & Company acting as co-managers.